Credits: Canva
After mpox outbreak, Africa is under the threat of yet another virus outbreak, this is the Marburg virus outbreak in Rwanda. So far, six people have died from the outbreak, confirmed the health minister. Most victims were the healthcare workers in the hospital's intensive care unit. As per reports, 20 cases have been identified since the outbreak was confirmed on Friday.
With the fatality rate of 8% it is the same virus family as Ebola. The main carrier is from fruit bats which spreads to humans then through the contact of bodily fluids of infected individuals, it spreads to others.
The common signs and symptoms of the Marburg virus include fever, pain, diarrhoea, vomiting and in the case of extreme blood loss, death too can happen.
So far, there is no specific treatment or vaccine for the virus. However, treatments like drugs and immune therapy are being developed as per the World Health Organisation (WHO).
Rwanda says that it has intensified its contact tracing, surveillance and testing to contain the spread. It has also tracked about 300 people who had come into contact with individuals affected by the Marburg virus.
The health minister has urged people to stay vigilant and avoid any physical contact and to wash their hands with clean water, soap or sanitiser and report any suspected case.
As of now, most of the cases have spread to the capital in Kigali. In light of this, the US Embassy in the city has advised its employees to work remotely for the next week.
This is the first time Rwanda has confirmed for Marburg cases, before this, in 2023, Tanzania confirmed the outbreak, whereas three people had died of this in Uganda in 2017.
As per WHO, this virus kills half of the people it infects. In the previous outbreaks, it has killed between 24% to 88% of the patients.
The virus was first detected in 1976 after 31 people were infected, out of which 7 died in simultaneous outbreak in Marburg and Frankfurt in Germany, and Belgrade in Serbia.
The source was traced to African green monkeys who were imported from Uganda. However, other animals too are linked to the virus spread, including bats.
In the past, the virus outbreaks have happened in countries like Equatorial Guinea, Ghana, the Democratic Republic of the Congo, Kenya, South Africa, Uganda, and Zimbabwe. In 2005, this virus killed 300 people in Angola.
However, for the rest of the world, only two people have died from the virus in the rest of the world, with one of them being in Europe, and the other in the US. These both have been on expeditions to caves in Uganda.
Credit: iStock
Vitiligo, an autoimmune condition that causes patches of skin to lose pigment, can be difficult to treat. Repigmentation often takes months, and results vary.
Now, two Phase 3 clinical trials, led by an international team of scientists from France, the US and Canada, found that an experimental oral drug, povorcitinib, improved skin pigmentation in adults with moderate-to-severe nonsegmental vitiligo.
Published in Nature Medicine, the trials STOP-V1 and STOP-V2 involved 916 adults and evaluated once-daily povorcitinib, which blocks JAK1, a protein involved in immune signalling. Key findings include:
Overall adverse event rates were broadly similar between the treatment and placebo groups. However, four patients receiving povorcitinib developed basal cell carcinoma, with one case considered treatment-related. One patient experienced blood-clotting complications, including pulmonary embolism and deep vein thrombosis, also considered treatment-related.
Although the findings are encouraging, most patients did not achieve at least 75% facial improvement, and substantial whole-body repigmentation remained uncommon. Longer-term safety data are also needed. Povorcitinib remains investigational and is not yet an established vitiligo treatment.
Vitiligo occurs when the immune system attacks melanocytes, the cells responsible for producing skin pigment. Although it is not life-threatening, it can significantly affect emotional and psychological well-being.
Speaking to HealthandMe, Dr Hetanshu Parekh, Consultant Plastic, Reconstructive and Cosmetic Surgeon, Bhailal Amin General Hospital, said vitiligo is more complex than a skin condition alone.
He explained that stress, sleep, diet and skin trauma may influence the disease.
Stress: Stress can disrupt immune balance and increase inflammation, potentially worsening vitiligo. New or expanding patches may appear following major life events, including illness, work pressure or bereavement.
Sleep: Chronic sleep deprivation and irregular sleep schedules may affect immune regulation and potentially worsen autoimmune conditions.
Diet: There is no specific vitiligo diet or food that can cure the condition. Deficiencies in vitamin B12, vitamin D, folate and copper may affect immune and skin health. A balanced diet rich in fruits, vegetables, whole grains, nuts, seeds and omega-3 fatty acids is recommended. Smoking and excessive alcohol consumption should be avoided.
Skin Protection: Friction, cuts, burns and other skin injuries may trigger new patches through a phenomenon known as the Koebner phenomenon. Regular sunscreen use, protective clothing and avoiding repeated skin trauma can help protect the skin.
Treatment depends on the extent and stability of the condition.
Credit: AI
Healthcare has emerged as a major concern in US midterm elections. Voters have been actively weighing surging medical costs, quality and access to reproductive healthcare, Medicaid funding and vaccination policies.
While the elections will determine control of Congress and several state legislatures, their outcome could also influence how Americans navigate healthcare, what treatments insurance plans cover and how public health programmes are funded.
Healthcare costs are particularly pressing for majority of Americans. An October KFF poll found that 25% of voters were very worried about affording healthcare, while another 35% were somewhat worried.
According to ABC News, rising insurance premiums, prescription drug costs and the growing use of expensive weight-loss GLP-1 medications are adding to these concerns.
Here are all the major healthcare issues at stake.
Also read: US Midterms 2026: 125 Doctors, Nurses And Health Experts Join Election Battle
Affordability is one of the biggest healthcare concerns for voters. The enhanced Affordable Care Act (ACA) premium tax credits expired at the end of 2025, increasing what many people pay for health insurance.
According to KFF, the average monthly benchmark premium for ACA coverage rose from $497 in 2025 to $625 in 2026. The benchmark silver premiums are projected to increase by an average of 13% in 2027.
The rising cost of insurance sponsored by employers, deductibles and prescription medicines has contributed to the burden. Experts are examining the contribution of healthcare AI tools, tariffs on medical supplies and increased spending on GLP-1 medications.
The debate centres on how to make healthcare more affordable. Democrats have been emphasising the restoration of ACA subsidies and Republicans highlighting alternative insurance policies and drug-pricing initiatives.
Medicaid, the government health insurance programme for Americans with low income, is another major election issue.
Changes introduced under the 2025 budget reconciliation law will bring new eligibility and work requirements. Starting January 1, 2027, most states will be required to implement work requirements for certain adults enrolled through Medicaid expansion.
Supporters argue that the requirements will encourage employment and protect public resources. Critics warn that administrative red tape, reporting requirements and difficulties documenting eligibility could cause people who qualify to lose coverage.
According to KFF, Congressional Budget Office projections cited in its analysis estimate that the Medicaid provisions could leave 7.5 million more people uninsured by 2034.
Also read: Trump Signs Women’s Health Order: Melania’s 5 Pillars of Innovation Explained
Abortion remains a major issue in several state-level elections, particularly after the overturning of Roe v. Wade in 2022, which put an end to the constitutional protection for abortion access.
According to the Guttmacher Institute, voters in four states will consider ballot measures related to abortion.
Idaho, Nevada and Virginia have measures seeking to protect reproductive freedom, while Missouri voters will decide whether to repeal established abortion protections.
Virginia’s measure includes protections related to contraception, fertility care, pregnancy and childbirth, while Nevada’s proposal seeks constitutional protection for abortion access. Idaho’s initiative would challenge the state’s abortion ban.
Missouri’s Amendment 3, meanwhile, seeks to reverse the reproductive freedom protections approved by voters in 2024.
The results could shape access to abortion and other reproductive healthcare services.
Vaccination and public health debates have also become politically inflammatory, especially amid the resurgence of measles in the United States.
The CDC reported 4,852 confirmed measles cases across 47 jurisdictions as of October 29, 2026. This compares with 2,289 cases reported during the whole of 2025. Nearly 96% of this year’s confirmed cases were linked with outbreaks.
Declining childhood vaccination coverage has contributed to the concerns. CDC data shows that MMR vaccination coverage among kindergarten children fell from 95.2% in the 2019–2020 school year to 92.4% in 2025–2026, below the 95% level that is generally needed to maintain community protection.
Federal vaccine policy has also become a subject of debate as changes to childhood vaccine recommendations and emphasis on individual decision making has drawn scrutiny from public health experts.
The cost of prescription medicines is another issue. Democrats have emphasised Medicare’s ability to negotiate prices for selected prescription drugs under the Inflation Reduction Act.
Republicans have highlighted the administration’s most-favoured-nation drug-pricing agreements, which seek to link US medicine prices to those paid in other developed countries.
The growing use of GLP-1 medications has also intensified the debate over prescription spending and insurance coverage.
A recent report stated that spending on GLP-1 medicines increased from $13.7 billion in 2018 to $71.7 billion in 2023. These medicines accounted for approximately 14% of US prescription drug spending in 2025, according to the American Society of Health-System Pharmacists.
The primary question for voters is whether proposed pricing measures will translate into lower costs and better access to essential medicines.
With all 435 seats in the House of Representatives and 33 Senate seats up for election, the midterm elections will determine the composition of the next Congress. Although healthcare is not the only issue for voters, rising medical costs, insurance affordability, reproductive rights and public health policies have become an important part of the debate.
Credit: Reuters
Spanish striker Jesus de Miguel, who played for Tenerife, died on Tuesday at the age of 30, a day after suffering a cardiac arrest following a collision during a match, the Spanish second-tier club said.
His death has brought attention to commotio cordis, a rare condition in which a sudden, blunt impact to the chest disrupts the heart's electrical rhythm and triggers cardiac arrest.
De Miguel collapsed following a clash with visiting goalkeeper Jesus Owono. Owono had rushed out of his area to clear a long ball and struck the forward with his knee.
De Miguel lay motionless as players from both teams signalled for medical assistance. Owono was shown a straight red card.
Medical staff treated De Miguel on the pitch for more than five minutes before he was taken to hospital by ambulance.
Police in Spain have opened proceedings for possible involuntary manslaughter following De Miguel's death, a source from the National Police said. The investigation is a routine procedure under Spanish law when a death is deemed non-natural.
"Racked with pain, with a lump in our throats and unable to believe that this is true, from CD Tenerife we communicate the tragic passing of Jesus de Miguel Alameda," the club said.
"There are no words of comfort; there is absolutely nothing that can alleviate this feeling overflowing with sadness."
De Miguel was born in Madrid in 1996 and joined Tenerife from Castellon ahead of the 2025-26 campaign, scoring 11 goals last season.
Tenerife confirmed that De Miguel died at 8 am local time on Tuesday. Spanish media subsequently reported that emergency-services specialist Javier G. Rendo had raised the possibility of commotio cordis, suggesting that the impact to the chest may have triggered an electrical disturbance in the heart. This has not been established as the confirmed cause of death.
According to Cleveland Clinic, commotio cordis occurs when a blow directly over the heart strikes at a particularly vulnerable moment in the heartbeat, triggering an abnormal rhythm called ventricular fibrillation.
It is most commonly associated with sports in which hard objects, such as baseballs, hockey pucks or lacrosse balls, hit the chest. A punch or other blunt impact can also trigger the condition under specific circumstances.
Commotio cordis is most common among young male athletes, particularly those under 20, with cases often reported around the age of 15.
Symptoms may include:
READ: Why Sleeping Pill Addiction Is Common Among Football Players
Yes. Commotio cordis can cause sudden cardiac arrest and can be fatal without immediate treatment.
The US National Commotio Cordis Registry documented 224 cases between 1996 and 2010, although its records have not been publicly updated since 2013. A 2026 review identified 434 reported cases worldwide. These figures refer to reported cases, not deaths.
However, prompt CPR and the use of an automated external defibrillator (AED) can improve the chances of survival.
Commotio cordis is a medical emergency. If someone collapses after a blow to the chest and is unresponsive or not breathing normally, immediate action is critical.
© $2026 Times Horizon Private Limited